Debra Zack's Insider Trades & SAST Disclosures

Debra Zack's most recent trade in Exagen Inc was a trade of 3,241 Common Stock done at an average price of $7.1 . Disclosure was reported to the exchange on March 1, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Exagen Inc
Debra Zack Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. 01 Mar 2022 3,241 84,259 (0%) 0% 7.1 23,076 Common Stock
Exagen Inc
Debra Zack Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2022 50,000 87,500 (0%) 0% 0 Common Stock
Exagen Inc
Debra Zack Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2021 37,500 37,500 (0%) 0% 0 Common Stock
Exagen Inc
Debra Zack Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2021 12,500 12,500 - - Stock Option(right to buy)
Exagen Inc
Debra Zack Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2020 100,000 100,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades